156 related articles for article (PubMed ID: 27790935)
1. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.
Sosa-Macías M; Teran E; Waters W; Fors MM; Altamirano C; Jung-Cook H; Galaviz-Hernández C; López-López M; Remírez D; Moya GE; Hernández F; Fariñas H; Ramírez R; Céspedes-Garro C; Tarazona-Santos E; LLerena A
Pharmacogenomics; 2016 Nov; 17(16):1741-1747. PubMed ID: 27790935
[TBL] [Abstract][Full Text] [Related]
2. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics: ethnicity, treatment and health in Latin American populations.
Sosa-Macías M; Fricke-Galindo I; Fariñas H; Monterde L; Ruiz-Cruz ED; Molina-Guarneros J; Tarazona-Santos E; Rodrigues-Soares F; Galaviz-Hernández C; Peñas-Lledó E; Moya G; Lara-Riegos J; Terán E; Hernández I; Ramírez-Roa R; Altamirano-Tinoco C; López-López M; García-Ortiz JE; LLerena A
Pharmacogenomics; 2023 Jun; 24(9):489-492. PubMed ID: 37529900
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
Rodeiro I; Remírez-Figueredo D; García-Mesa M; Dorado P; LLerena A;
Drug Metabol Drug Interact; 2012; 27(1):57-60. PubMed ID: 22718626
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014).
Sosa-Macias M; Moya GE; LLerena A; Ramírez R; Terán E; Peñas-LLedó EM; Tarazona-Santos E; Galaviz-Hernández C; Céspedes-Garro C; Acosta H
Pharmacogenomics; 2015; 16(7):673-6. PubMed ID: 25929854
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.
Peñas-LLedó E; Terán E; Sosa-Macías M; Galaviz-Hernández C; Gil JP; Nair S; Diwakar S; Hernández I; Lara-Riegos J; Ramírez-Roa R; Verde I; Tarazona-Santos E; Molina-Guarneros J; Moya G; Rägo L; LLerena A
Clin Ther; 2020 Aug; 42(8):1595-1610.e5. PubMed ID: 32782137
[TBL] [Abstract][Full Text] [Related]
7. Conference scene: Latin American Pharmacogenomics and Personalized Medicine Conference.
Suarez-Kurtz G
Pharmacogenomics; 2012 Oct; 13(13):1449-52. PubMed ID: 23057544
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics in Central American healthy volunteers: interethnic variability.
Céspedes-Garro C; Naranjo ME; Ramírez R; Serrano V; Fariñas H; Barrantes R; LLerena A;
Drug Metab Pers Ther; 2015 Mar; 30(1):19-31. PubMed ID: 25490028
[TBL] [Abstract][Full Text] [Related]
9. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).
Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
Drug Metab Pers Ther; 2016 Jun; 31(2):61-81. PubMed ID: 26812836
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
[TBL] [Abstract][Full Text] [Related]
11. Population Diversity in Pharmacogenetics: A Latin American Perspective.
Suarez-Kurtz G; Parra EJ
Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
[TBL] [Abstract][Full Text] [Related]
12. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
[TBL] [Abstract][Full Text] [Related]
13. Exploring the impact of pharmacogenetics on personalized medicine: A systematic review.
Amaro-Álvarez L; Cordero-Ramos J; Calleja-Hernández MÁ
Farm Hosp; 2024 Feb; ():. PubMed ID: 38341366
[TBL] [Abstract][Full Text] [Related]
14. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
[TBL] [Abstract][Full Text] [Related]
15. State of Art of Cancer Pharmacogenomics in Latin American Populations.
López-Cortés A; Guerrero S; Redal MA; Alvarado AT; Quiñones LA
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545225
[TBL] [Abstract][Full Text] [Related]
16. Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America.
de la Cruz C; de Carvalho AV; Dorantes GL; Londoño Garcia AM; Gonzalez C; Maskin M; Podoswa N; Redfern JS; Valenzuela F; van der Walt J; Romiti R
J Dermatol; 2017 Jan; 44(1):3-12. PubMed ID: 27461455
[TBL] [Abstract][Full Text] [Related]
17. Conference report: pharmacogenomics in special populations at WCP2018.
Suarez-Kurtz G; Aklillu E; Saito Y; Somogyi AA
Br J Clin Pharmacol; 2019 Mar; 85(3):467-475. PubMed ID: 30537134
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and obstacles in genotypic prediction of cytochrome P450 phenotypes.
McGraw J; Gerhardt A; Morris TC
Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):659-661. PubMed ID: 29863909
[No Abstract] [Full Text] [Related]
19. Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative.
Esperón P; Martínez MF; Redal MA; Lazarowski A; López-Cortés A; Varela NM; Quiñones LA
Front Pharmacol; 2021; 12():833000. PubMed ID: 35087412
[No Abstract] [Full Text] [Related]
20. P450 Pharmacogenetics in Indigenous North American Populations.
Henderson LM; Claw KG; Woodahl EL; Robinson RF; Boyer BB; Burke W; Thummel KE
J Pers Med; 2018 Feb; 8(1):. PubMed ID: 29389890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
